Global cancer cases expected to increase 77 percent by 2050: WHO report

The World Health Organization expects global cancer cases to increase by 77 percent by 2050, according to a new report from the United Nations agency.

of The data was released on Friday The organization’s International Agency for Research on Cancer (IARC) examined 2022 data on 36 cancer types from more than 185 countries.

IARC revealed that 10 types of cancer accounted for two-thirds of new infections and deaths worldwide in 2022.

The most common cancer was lung cancer, with 2.5 million new cases. Female breast cancer ranked second with 2.3 million new cases, followed by colorectal cancer with 1.9 million new cases and prostate cancer with 1.5 million new cases.

According to the report, 1.8 million people died from lung cancer, accounting for 18.7% of all cancer deaths in 2022.

Cervical cancer was the most common cancer in women in 25 countries, including many countries in sub-Saharan Africa.

The report found that in countries with a low Human Development Index (HDI), women are less likely to be diagnosed with breast cancer but more likely to die from breast cancer due to “delayed diagnosis and lack of access to high-quality treatment.” It turned out to be highly sexual.

of HDI This is the WHO’s Summary Scale of Human Development. It is a measure of a country’s average performance based on its population’s health, knowledge, and standard of living.

“A new WHO global survey highlights the huge inequalities and lack of economic protection against cancer around the world, with people in low-income countries especially unable to access basic cancer treatment.” said Dr. Bente Mikkelsen of the ministry. The WHO report on non-communicable diseases states:

The organization predicts there will be 35 million new cancer cases by 2050. This projection reflects an aging and growing population, as well as exposure to risk factors such as tobacco, alcohol, obesity, and the environment.

“The impact of this increase will not be felt equally across countries with different HDI levels. Those with the least resources to manage the burden of cancer will bear the brunt of the global cancer burden. Dr. Freddie Bray, IARC’s head of cancer surveillance, said in the report.